Cal-Maine Foods Earnings Calls
| Release date | Jul 28, 2026 |
| EPS estimate | $0.576 |
| EPS actual | - |
| Revenue estimate | 642.167M |
| Revenue actual | - |
| Expected change | +/- 5.11% |
| Release date | Apr 01, 2026 |
| EPS estimate | $0.696 |
| EPS actual | $1.06 |
| EPS Surprise | 52.30% |
| Revenue estimate | 642.481M |
| Revenue actual | 666.951M |
| Revenue Surprise | 3.81% |
| Release date | Jan 07, 2026 |
| EPS estimate | $1.95 |
| EPS actual | $2.13 |
| EPS Surprise | 9.23% |
| Revenue estimate | 796.588M |
| Revenue actual | 769.498M |
| Revenue Surprise | -3.40% |
| Release date | Oct 01, 2025 |
| EPS estimate | $5.01 |
| EPS actual | $4.12 |
| EPS Surprise | -17.76% |
| Revenue estimate | 960.313M |
| Revenue actual | 922.602M |
| Revenue Surprise | -3.93% |
Last 4 Quarters for Cal-Maine Foods
Below you can see how CALM performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 01, 2025 |
| Price on release | $92.96 |
| EPS estimate | $5.01 |
| EPS actual | $4.12 |
| EPS surprise | -17.76% |
| Date | Price |
|---|---|
| Sep 25, 2025 | $97.49 |
| Sep 26, 2025 | $98.43 |
| Sep 29, 2025 | $96.12 |
| Sep 30, 2025 | $94.10 |
| Oct 01, 2025 | $92.96 |
| Oct 02, 2025 | $92.58 |
| Oct 03, 2025 | $92.56 |
| Oct 06, 2025 | $92.77 |
| Oct 07, 2025 | $92.87 |
| 4 days before | -4.65% |
| 4 days after | -0.0968% |
| On release day | -0.409% |
| Change in period | -4.74% |
| Release date | Jan 07, 2026 |
| Price on release | $77.81 |
| EPS estimate | $1.95 |
| EPS actual | $2.13 |
| EPS surprise | 9.23% |
| Date | Price |
|---|---|
| Dec 31, 2025 | $79.57 |
| Jan 02, 2026 | $78.47 |
| Jan 05, 2026 | $79.07 |
| Jan 06, 2026 | $79.08 |
| Jan 07, 2026 | $77.81 |
| Jan 08, 2026 | $75.46 |
| Jan 09, 2026 | $73.69 |
| Jan 12, 2026 | $73.86 |
| Jan 13, 2026 | $72.44 |
| 4 days before | -2.21% |
| 4 days after | -6.90% |
| On release day | -3.02% |
| Change in period | -8.96% |
| Release date | Apr 01, 2026 |
| Price on release | $83.36 |
| EPS estimate | $0.696 |
| EPS actual | $1.06 |
| EPS surprise | 52.30% |
| Date | Price |
|---|---|
| Mar 26, 2026 | $78.70 |
| Mar 27, 2026 | $77.12 |
| Mar 30, 2026 | $78.66 |
| Mar 31, 2026 | $79.15 |
| Apr 01, 2026 | $83.36 |
| Apr 02, 2026 | $78.10 |
| Apr 06, 2026 | $78.97 |
| Apr 07, 2026 | $77.24 |
| Apr 08, 2026 | $77.07 |
| 4 days before | 5.92% |
| 4 days after | -7.55% |
| On release day | -6.31% |
| Change in period | -2.07% |
| Release date | Jul 28, 2026 |
| Price on release | - |
| EPS estimate | $0.576 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 28, 2026 | $76.49 |
| May 29, 2026 | $74.72 |
| Jun 01, 2026 | $75.14 |
| Jun 02, 2026 | $74.53 |
| Jun 03, 2026 | $75.35 |
Cal-Maine Foods Earnings Call Transcript Summary of Q1 2026
Cal-Maine reported a record first quarter (FY2026) driven by growth in specialty eggs and the recent Echo Lake prepared foods acquisition. Net sales were $922.6M (up 17.4% YoY); gross profit was $311.3M (33.7% of sales) and operating income was $249.2M (27% of sales). Net income was $199.3M, or $4.12 diluted EPS. Shell egg sales remained the majority of revenue (85.6%), while specialty eggs and prepared foods comprised ~40% of sales combined, with specialty >30% and prepared foods >9% this quarter. Key operational drivers included higher shell egg selling prices, a 7.5% increase in specialty egg volumes, lower feed costs (feed down ~4% per dozen), breeder and layer flock rebuild (breeders +46%, chicks hatched +77%, layers +10%), and strong operating cash flow ($278.6M). The company is virtually debt-free with $252M cash and $1B in investments. Capital allocation priorities: maintain dividend (announced $1.37 per share payable Nov 13), opportunistic share repurchases, disciplined reinvestment and M&A (prepared foods a strategic focus), and pursuit of multiple expansion via mix shift to higher-value, more predictable earnings. Management emphasized continued investment in biosecurity (> $80M since 2015), vertical integration, and operational excellence. Echo Lake is performing at or above expectations, with an approved $14.8M pancake line expansion and targeted synergies (~$15M). Management cautioned that highly pathogenic avian influenza (HPAI) remains a global risk to supply and that seasonality and supply stabilization will influence market pricing near term.
Sign In
Buy CALM